Table 6.
Gene | Differential Expression* | Differential Expression** | Description |
---|---|---|---|
LILRB1 | ↓ | ↓ | Leukocyte immunoglobulin-like receptor, subfamily A |
C9orf47 | ↓ | ↓ | Endo differentiation, sphingolipid G-protein-coupled receptor, 3 |
NRN1 | ↓ | ↓ | Homo sapiens neuritin |
PLCB4 | ↓ | ↓ | Phospholipase C, beta 4 |
GATA6 | ↓ | ↓ | Homo sapiens mRNA for GATA-6 |
THY1 | ↓ | ↓ | Thy-1 cell surface antigen |
LRRC15 | ↓ | ↓ | Leucine-rich repeat containing 5 |
MAB21L2 | ↑ | ↑ | Homo sapiens MAB21L2 protein |
CES1 | ↑ | ↑ | Carboxylesterase |
SFRP2 | ↑ | ↑ | Secreted frizzled-related protein 2 |
SEMA3A | ↓ | ↑ | Sema domain, immunoglobulin domain (Ig), (semaphorin) 3A |
SFRP1 | ↓ | ↑ | Secreted frizzled-related protein 1 |
LMO2 | ↓ | ↑ | LIM domain only 2 |
CRLF1 | ↓ | ↑ | Cytokine receptor-like factor 1 |
TMOD1 | ↓ | ↑ | Homo sapiens, tropomodulin |
PRG4 | ↓ | ↑ | Proteoglycan 4 |
HLA-DQA1 | ↑ | ↓ | MHC class II, DQ alpha 1 |
HLA-DRA | ↑ | ↓ | MHC class 22 HLA-DR-alpha |
HLA-DRB4 | ↑ | ↓ | MHC class II DR beta 4 |
CTSC | ↑ | ↓ | Cathepsin C |
TBX5 | ↑ | ↓ | ESTs, AW269421 |
HOXD13 | ↑ | ↓ | Homeo box D13 |
BST1 | ↑ | ↓ | Bone marrow stromal cell antigen 1 |
This study.
Previously reported17.
↑ indicates elevated expression in hTERT-OA 13A FLS (passage 25) compared to hTERT-RA 516 FLS (passage 25) or in primary OA FLS (passage 2−3) compared to primary RA FLS (passages 2−3). ↓ indicates decreased expression in hTERT-OA 13A FLS (passage 25) compared to hTERT-RA 516 FLS (passage 25) or in primary OA FLS (passages 2−3) compared to primary RA FLS (passages 2−3).